Jump to ContentJump to Main Navigation
Balancing Wealth and HealthThe Battle over Intellectual Property and Access to Medicines in Latin America$
Users without a subscription are not able to see the full content.

Rochelle Dreyfuss and César Rodríguez-Garavito

Print publication date: 2014

Print ISBN-13: 9780199676743

Published to Oxford Scholarship Online: May 2014

DOI: 10.1093/acprof:oso/9780199676743.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 19 September 2019

The Role of WIPO in Access to Medicines

The Role of WIPO in Access to Medicines

Chapter:
(p.307) Chapter 13 The Role of WIPO in Access to Medicines
Source:
Balancing Wealth and Health
Author(s):

Ruth L. Okediji

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199676743.003.0013

This chapter examines the role of the World Intellectual Property Organization (WIPO). It reflects on the WIPO's mandate in an international environment in which competing visions of the IP system continue to engender challenges to the norms WIPO is tasked to supply and defend. It discusses the WIPO's role in the implementation of the Trade-Related Aspects of Intellectual Property (TRIPS) Agreement, and the WIPO and TRIPS Agreement in relation to public health.

Keywords:   World Intellectual Property Organization, intellectual property system, Trade-Related Aspects of Intellectual Property Agreement, TRIPS

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .